A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity
暂无分享,去创建一个
T. Roskams | Y. Hoshida | C. Schuster | E. Crouchet | T. Baumert | L. Mailly | M. Vyberg | R. Iacone | M. Zeisel | P. Pessaux | B. Fuchs | Frank Jühling | Antonio Saviano | S. Moll | Jacopo Sgrignani | C. De Vito | J. Lupberger | Z. Nehme | D. Heide | M. Heikenwälder | G. Elson | S. Cherradi | B. Viuff | E. Felli | E. Galsgaard | F. Del Zompo | M. Hofmann | F. Duong | T. Schweighoffer | C. Thumann | Laura Heydmann | S. Durand | Houssein El Saghire | Marine A. Oudot | O. Koutsopoulos | C. Ponsolles | Geoffrey Teixeira | A. Toso | Natascha Roehlen | Andrea Cavalli | Irwin Davidson | M. Meyer | Antonin Lallement | Victor Gonzalez Motos | Nuno Almeida | Tessa Ostyn | A. Lallement
[1] H. Moseley,et al. Hepatic kinome atlas: An in‐depth identification of kinase pathways in liver fibrosis of humans and rodents , 2022, Hepatology.
[2] A. Regev,et al. Single‐Cell, Single‐Nucleus, and Spatial RNA Sequencing of the Human Liver Identifies Cholangiocyte and Mesenchymal Heterogeneity , 2021, Hepatology communications.
[3] A. Regev,et al. A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery , 2021, Nature Communications.
[4] J. Groten,et al. Kinase activity profiling identifies putative downstream targets of cGMP/PKG signaling in inherited retinal neurodegeneration , 2021, bioRxiv.
[5] R. Bourgon,et al. Cross-tissue organization of the fibroblast lineage , 2021, Nature.
[6] T. Luedde,et al. JNK signaling prevents biliary cyst formation through a CASPASE-8–dependent function of RIPK1 during aging , 2021, Proceedings of the National Academy of Sciences.
[7] K. Cusi,et al. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis. , 2020, The New England journal of medicine.
[8] Raphael Gottardo,et al. Integrated analysis of multimodal single-cell data , 2020, Cell.
[9] I. Goldstein,et al. Protocol for Primary Mouse Hepatocyte Isolation , 2020, STAR protocols.
[10] Asher Mullard. FDA rejects NASH drug , 2020, Nature Reviews Drug Discovery.
[11] J. Loyd,et al. Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis , 2020, Science Advances.
[12] N. Habib,et al. Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug. , 2020, Molecular therapy : the journal of the American Society of Gene Therapy.
[13] Alexandre M.J.J. Bonvin,et al. A protocol for information-driven antibody-antigen modelling with the HADDOCK2.4 webserver , 2020, 2005.03283.
[14] E. Crouchet,et al. Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives , 2020, Cells.
[15] A. Ortiz,et al. Targeting the progression of chronic kidney disease , 2020, Nature Reviews Nephrology.
[16] Sungjin Ko,et al. Liver Progenitors and Adult Cell Plasticity in Hepatic Injury and Repair: Knowns and Unknowns. , 2020, Annual review of pathology.
[17] Jim Freeth,et al. New Advances in Cell Microarray Technology to Expand Applications in Target Deconvolution and Off-Target Screening , 2019, SLAS discovery : advancing life sciences R & D.
[18] Victoria Sanz-Moreno,et al. Faculty Opinions recommendation of QuPath: Open source software for digital pathology image analysis. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[19] R. Irizarry. ggplot2 , 2019, Introduction to Data Science.
[20] B. Neuschwander‐Tetri,et al. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial , 2019, The Lancet.
[21] Jonathan A. Kropski,et al. Single-cell RNA-sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis , 2019, bioRxiv.
[22] C. Ponting,et al. Resolving the fibrotic niche of human liver cirrhosis at single cell level , 2019, Nature.
[23] S. Carr,et al. Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development. , 2019, Gastroenterology.
[24] Dominic Grün,et al. A Human Liver Cell Atlas reveals Heterogeneity and Epithelial Progenitors , 2019, Nature.
[25] K. Beningo,et al. Integrins, CAFs and Mechanical Forces in the Progression of Cancer , 2019, Cancers.
[26] M. Imamura,et al. HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response , 2019, Gastroenterology.
[27] Robert Abel,et al. OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules. , 2019, Journal of chemical theory and computation.
[28] S. Glaser,et al. Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances , 2018, Hepatology.
[29] M. Strek,et al. Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence , 2018, European Respiratory Review.
[30] Jean-Charles Carvaillo,et al. TTClust: A Versatile Molecular Simulation Trajectory Clustering Program with Graphical Summaries , 2018, J. Chem. Inf. Model..
[31] P. Dhawan,et al. Tight junction proteins in gastrointestinal and liver disease , 2018, Gut.
[32] V. de Lédinghen,et al. Noninvasive biomarkers in NAFLD and NASH — current progress and future promise , 2018, Nature Reviews Gastroenterology & Hepatology.
[33] Scott R. Presnell,et al. Modeling NAFLD using 3D bioprinted human liver tissue , 2018 .
[34] Yi Wang,et al. Predictive model for inflammation grades of chronic hepatitis B: Large‐scale analysis of clinical parameters and gene expressions , 2017, Liver international : official journal of the International Association for the Study of the Liver.
[35] Maria Ryaboshapkina,et al. Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis , 2017, Scientific Reports.
[36] D. Calvisi,et al. Animal models of biliary injury and altered bile acid metabolism. , 2017, Biochimica et biophysica acta. Molecular basis of disease.
[37] Russell B. Fletcher,et al. Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics , 2017, BMC Genomics.
[38] T. Baumert,et al. Humanisation of a claudin-1-specific monoclonal antibody for clinical prevention and cure of HCV infection without escape , 2017, Gut.
[39] Junfeng Du,et al. CLDN-1 promoted the epithelial to migration and mesenchymal transition (EMT) in human bronchial epithelial cells via Notch pathway , 2017, Molecular and Cellular Biochemistry.
[40] Peter Bankhead,et al. QuPath: Open source software for digital pathology image analysis , 2017, Scientific Reports.
[41] A. Subramanian,et al. Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition. , 2016, Cancer cell.
[42] Garrett M. Dancik,et al. shinyGEO: a web-based application for analyzing gene expression omnibus datasets , 2016, Bioinform..
[43] Hans Clevers,et al. Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation , 2016, Nature Protocols.
[44] T. Hibi,et al. Development of a novel mouse model of hepatocellular carcinoma with nonalcoholic steatohepatitis using a high-fat, choline-deficient diet and intraperitoneal injection of diethylnitrosamine , 2016, BMC Gastroenterology.
[45] V. Lagente,et al. Involvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosis , 2016, Bioscience reports.
[46] T. Ye,et al. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis , 2016, Journal of Virology.
[47] G. Damm,et al. Protocol for Isolation of Primary Human Hepatocytes and Corresponding Major Populations of Non-parenchymal Liver Cells. , 2016, Journal of visualized experiments : JoVE.
[48] G C P van Zundert,et al. The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of Biomolecular Complexes. , 2016, Journal of molecular biology.
[49] N. Pochet,et al. A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses , 2016, Hepatology.
[50] J. Mesirov,et al. The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .
[51] P. Giraudi,et al. The interplay between hepatic stellate cells and hepatocytes in an in vitro model of NASH. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.
[52] R. Kalluri,et al. Epithelial to Mesenchymal Transition induces cell cycle arrest and parenchymal damage in renal fibrosis , 2015, Nature Medicine.
[53] P. Roingeard,et al. Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C , 2015, PloS one.
[54] Anna Vangone,et al. Contacts-based prediction of binding affinity in protein–protein complexes , 2015, eLife.
[55] Don C Rockey,et al. Fibrosis--a common pathway to organ injury and failure. , 2015, The New England journal of medicine.
[56] Georges Noel,et al. Three-Dimensional Cell Culture: A Breakthrough in Vivo , 2015, International journal of molecular sciences.
[57] Lars Kaderali,et al. Clearance of persistent hepatitis C virus infection using a claudin-1-targeting monoclonal antibody , 2015, Nature Biotechnology.
[58] Noeris K. Salam,et al. Structure-based approach to the prediction of disulfide bonds in proteins. , 2014, Protein engineering, design & selection : PEDS.
[59] M. Mahajan,et al. A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration , 2014, Gut.
[60] Richard Friesner,et al. Antibody structure determination using a combination of homology modeling, energy‐based refinement, and loop prediction , 2014, Proteins.
[61] P. Kaposi-Novák,et al. Increased Expression of Claudin-1 and Claudin-7 in Liver Cirrhosis and Hepatocellular Carcinoma , 2014, Pathology & Oncology Research.
[62] S. Murphy,et al. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease , 2014, Hepatology.
[63] Hege S. Beard,et al. Applying Physics-Based Scoring to Calculate Free Energies of Binding for Single Amino Acid Mutations in Protein-Protein Complexes , 2013, PloS one.
[64] G. Yoon,et al. Claudin-1 induces epithelial–mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells , 2013, Oncogene.
[65] L. Guarente,et al. Renal tubular Sirt1 attenuates diabetic albuminuria by epigenetically suppressing Claudin-1 overexpression in podocytes , 2013, Nature Medicine.
[66] Yuchang Li,et al. Mesothelial cells give rise to hepatic stellate cells and myofibroblasts via mesothelial–mesenchymal transition in liver injury , 2013, Proceedings of the National Academy of Sciences.
[67] Kerstin Pingel,et al. 50 Years of Image Analysis , 2012 .
[68] P. Schirmacher,et al. Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response. , 2012, Gastroenterology.
[69] M. Katze,et al. Early transcriptional programming links progression to hepatitis C virus–induced severe liver disease in transplant patients , 2012, Hepatology.
[70] Kevin W Eliceiri,et al. NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.
[71] Hyeon Joo,et al. OPM database and PPM web server: resources for positioning of proteins in membranes , 2011, Nucleic Acids Res..
[72] T. Luedde,et al. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury , 2011, Gut.
[73] M. Tsujikawa,et al. Tumor-associated calcium signal transducer 2 is required for the proper subcellular localization of claudin 1 and 7: implications in the pathogenesis of gelatinous drop-like corneal dystrophy. , 2010, The American journal of pathology.
[74] J. McKeating,et al. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes. , 2010, Gastroenterology.
[75] Arvind H. Patel,et al. Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation , 2010, The Journal of experimental medicine.
[76] B. Thornhill,et al. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. , 2009, Kidney international.
[77] H. Bolte,et al. Standardized quantification of pulmonary fibrosis in histological samples. , 2008, BioTechniques.
[78] Aarati R. Ranade,et al. Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− mice , 2007, Nature Biotechnology.
[79] Charles M. Rice,et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry , 2007, Nature.
[80] M. Hall,et al. TOR Signaling in Growth and Metabolism , 2006, Cell.
[81] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[82] Naftali Kaminski,et al. Up-Regulation and Profibrotic Role of Osteopontin in Human Idiopathic Pulmonary Fibrosis , 2005, PLoS medicine.
[83] O. Cummings,et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.
[84] B. Honig,et al. A hierarchical approach to all‐atom protein loop prediction , 2004, Proteins.
[85] C. Dominguez,et al. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.
[86] Z. Xiang,et al. On the role of the crystal environment in determining protein side-chain conformations. , 2002, Journal of molecular biology.
[87] H. Berman,et al. Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank , 2022 .
[88] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[89] S. Crawford,et al. Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants. , 2001, The Journal of infectious diseases.
[90] M. Klein,et al. Constant pressure molecular dynamics algorithms , 1994 .
[91] M. Klein,et al. Nosé-Hoover chains : the canonical ensemble via continuous dynamics , 1992 .
[92] J M Simpson,et al. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. , 1988, Journal of clinical pathology.
[93] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[94] J. Mesirov,et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.
[95] D. Brandeis,et al. A Review of Current Evidence , 2014 .
[96] R. Hilhorst,et al. Peptide microarrays for profiling of serine/threonine kinase activity of recombinant kinases and lysates of cells and tissue samples. , 2013, Methods in molecular biology.
[97] Cedric E. Ginestet. ggplot2: Elegant Graphics for Data Analysis , 2011 .
[98] G. Davies,et al. Knowns and Unknowns , 2003 .
[99] R. Tibshirani,et al. Estimating the number of clusters in a data set via the gap statistic , 2000 .